Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07574866

A Retrospective Study on Clinical Characteristics and Outcomes of Patients With Pneumonia

Retrospective Analysis of Clinical Characteristics and Prognostic Factors in Hospitalized Pneumonia Patients from April 2023 to April 2026. Background: Pneumonia remains the leading cause of death from infectious diseases in adults worldwide, with an increasingly severe disease burden exacerbated by population aging and the frequent emergence of drug-resistant bacteria; in China, severe pneumonia accounts for a striking 13.58% to 20.05% of hospitalized cases. In recent years, shifts in the pathogen spectrum (e.g., COVID-19, influenza A) and patient demographic characteristics have posed new challenges for clinical management. However, existing studies mostly focus on single pathogens or specific populations (e.g., ICU patients), lacking systematic analyses of the full-disease course characteristics of general hospitalized pneumonia patients. Furthermore, in the post-pandemic era, the clinical phenotypes, treatment responses, and prognostic factors of pneumonia may have evolved, necessitating evidence-based support from real-world data. This study aims to conduct a retrospective analysis to clarify the epidemiological characteristics, etiological distribution, and prognostic factors influencing current hospitalized pneumonia patients, thereby providing a basis for optimizing diagnosis and treatment strategies.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 18 years old;
  • Meet the diagnostic criteria for pneumonia (acute onset + new infiltrates on imaging);
  • Have a positive result from pathogen testing;
  • Time from onset to admission ≤ 72 hours (to ensure being in the acute phase of the disease);
  • Sign a written informed consent form.

Inclusion criteria

for the severe group:

A diagnosis of "severe pneumonia" can be made if one of the main criteria or ≥ 3 of the secondary criteria are met.

Main criteria:

① Tracheal intubation requiring mechanical ventilation

② Need for vasoactive drugs after active fluid resuscitation for septic shock

Secondary criteria:

  • Respiratory rate ≥ 30 breaths/min
  • PaO₂/FiO₂ ≤ 250 mm Hg
  • Multiple lobe infiltrates
  • Confusion and/or disorientation ⑤ Blood urea nitrogen ≥ 20 mg/dL

⑥ Leukopenia (WBC < 4×10⁹/L)

  • Thrombocytopenia (PLT < 100×10⁹/L)
  • Decreased body temperature (central body temperature < 36 ℃) ⑨ Hypotension requiring fluid resuscitation

Exclusion criteria

  • 1) Patients with severely lacking medical records;
  • Those whose main manifestations are other non-infectious diseases (such as pulmonary edema, lung cancer, pulmonary embolism, etc.); 3) Those whose main diagnosis is active pulmonary tuberculosis, non-infectious interstitial lung disease, etc.; 4) Patients considered not applicable by the researchers.

Treatment and study plan

Primary outcomes

  1. 28-day all-cause mortality rate

    Time frame: 28 days after admission

Secondary outcomes

  1. Demographic characteristics

    Time frame: 28 days after admission

    Demographic data (age, sex, etc.)

  2. Comorbidities

    Time frame: 28 days after admission

    Comorbidities, such as chronic obstructive pulmonary disease (COPD), diabetes mellitus, and cardiovascular diseases.

  3. Symptomatic manifestations

    Time frame: 28 days after admission

    Symptomatic manifestations (e.g., fever, cough, dyspnea)

  4. Laboratory tests

    Time frame: 28 days after admission

    Laboratory tests (including blood routine, liver and kidney function, etc.)

  5. Imaging Examination

    Time frame: 28 days after admission

    Imaging Examination: Radiological manifestations and image data from chest X-ray or CT scans

  6. ICU Length of Stay

    Time frame: 28 days after admission

  7. Duration of Mechanical Ventilation

    Time frame: 28 days after admission

  8. Length of Hospital Stay

    Time frame: 28 days after admission

Other outcomes

  1. Utilization of Antimicrobial Agents

    Time frame: 28 days after admission

  2. Clinical Outcomes (cured, improved, deceased)

    Time frame: 28 days after admission

Study contacts

Contact information is provided by the study sponsor or research team.

Liang Peng, Doctor

CONTACT

[email protected]

86-020-85959142

Sponsors and collaborators

Lead sponsor

Zhonghao Fang

Other

Collaborators

  • Fifth Affiliated Hospital of Guangzhou Medical University

Registry information

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
May 8, 2026
Registry last updated
May 8, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.